Clinical trial

18F Labeled FAP Targeted Molecular Probe in Early Tumor Diagnosis

NCT06937112

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-04-10

PhaseN/A

Study timeline

Study start (actual)2025-04-10Date precision: day

Registry last updated2025-04-22

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancersunresolved

Pancreatic Cancerunresolved

Neuroendocrine Tumorsunresolved

Thyroid Cancerunresolved

Interventions

PET-CT examinationOTHER

Sponsors & collaborators

Nanjing First Hospital, Nanjing Medical Universitylead sponsor

Mapped research locations

NanjingJiangsu, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06937112 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.